Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation

Background and Purpose  Oral anticoagulants (OACs) prevent stroke recurrence and vascular embolism in patients with acute ischemic stroke (AIS) and atrial fibrillation (AF). Based on empirical consensus, current guidance recommends a “1–3–6–12 days” rule to resume OACs after AIS. This study investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Po-Yin, Wang, Wei-Ting, Wu, Wei-Lun, Chang, Hui-Chin, Chen, Chen-Huan, Tsai, Yi-Wen, Chiou, Shih-Hwa, Lip, Gregory Y. H., Cheng, Hao-Min, Chiang, Chern-En
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251709/
https://www.ncbi.nlm.nih.gov/pubmed/34649296
http://dx.doi.org/10.1055/a-1669-4987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251709/
https://www.ncbi.nlm.nih.gov/pubmed/34649296
http://dx.doi.org/10.1055/a-1669-4987

Ejemplares similares